Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1619044

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1619044

Pain Management Market Size, Share, Growth Analysis, By Types (Non-Steroidal Anti-Inflammatory Drugs, Anticonvulsants), By Indication, By Mode of Purchase, By End-User, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Pain Management Market size was valued at USD 75.2 billion in 2022 and is poised to grow from USD 78.43 billion in 2023 to USD 109.84 billion by 2031, growing at a CAGR of 4.3% during the forecast period (2024-2031).

The global pain management market is experiencing robust growth, fueled by the rising prevalence of chronic pain conditions like arthritis, cancer pain, and musculoskeletal disorders. As chronic pain significantly impacts daily life, the demand for effective pain relief solutions is escalating. Advances in technology and treatment options, including novel pharmaceuticals and minimally invasive procedures, enhance the approach healthcare professionals can take to manage pain effectively. However, the market faces challenges such as the opioid crisis, leading to heightened regulations and a shift towards non-opioid alternatives. Additionally, high treatment costs and varying reimbursement policies can limit access for underserved populations. The subjective nature of pain complicates personalized treatment strategies, necessitating a nuanced understanding of each patient's situation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pain Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pain Management Market Segmental Analysis

Global Pain Management Market is segmented by types, indication, mode of purchase, end-user and region. Based on types, the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), anticonvulsants, sedatives, narcotics, antimigraine specialists, antidepressants and others. Based on indication, the market is segmented into delegated neuropathic torment, disease torment, facial agony and headache, musculoskeletal torment, fibromyalgia, persistent back torment, joint torment, headache and post-usable torment. Based on mode of purchase, the market is segmented into over the counter and solution-based. Based on end-user, the market is segmented into emergency clinics and facilities, drug organizations, clinical gadget organizations, examination and educational establishments. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pain Management Market

The Global Pain Management market is significantly driven by a heightened awareness regarding the effects of pain on individuals' quality of life. As healthcare providers, patients, and policymakers increasingly recognize the importance of effective pain relief, there's a concerted effort aimed at enhancing research, education, and accessibility to pain management solutions. This growing commitment to patient-centric care coupled with the desire for improved outcomes in pain management is propelling the market forward. Emphasizing effective strategies for relieving pain not only benefits individuals but also fosters advancements in the overall healthcare landscape, further driving interest and investment in this vital sector.

Restraints in the Global Pain Management Market

The Global Pain Management market faces significant constraints due to the high expense associated with treatments. Advanced procedures, devices, and specialized therapies often come with steep price tags that can hinder market growth. This financial barrier particularly affects access for various patient populations, particularly in low-income areas or countries with constrained healthcare resources. Consequently, many individuals may be unable to afford necessary pain management interventions, which can result in untreated conditions and overall suboptimal health outcomes. As a result, the high cost of these treatments remains a critical factor slowing the expansion of the pain management market worldwide.

Market Trends of the Global Pain Management Market

The Global Pain Management market is experiencing a significant trend towards multimodal and individualized approaches, reflecting a shift in how pain is managed. This trend encompasses the integration of diverse therapies-ranging from pharmacological treatments and physical therapy to psychological interventions and lifestyle modifications-allowing for comprehensive care that addresses pain from multiple dimensions. As healthcare providers increasingly recognize the importance of tailoring pain management strategies to each patient's unique circumstances-including the nature of their pain, existing comorbidities, and personal preferences-this evolving paradigm is expected to enhance patient outcomes and drive substantial growth within the market through more effective, personalized treatment options.

Product Code: SQMIG35I2271

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Pain Management Market Size by Types & CAGR (2024-2031)

  • Market Overview
  • Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
  • Anticonvulsants
  • Sedatives
  • Narcotics
  • Antimigraine Specialists
  • Antidepressants
  • Others

Global Pain Management Market Size by Indication & CAGR (2024-2031)

  • Market Overview
  • Delegated Neuropathic Torment
  • Disease Torment
  • Facial Agony and Headache
  • Musculoskeletal Torment
  • Fibromyalgia
  • Persistent Back Torment
  • Joint Torment
  • Headache
  • Post-Usable Torment

Global Pain Management Market Size by Mode Of Purchase & CAGR (2024-2031)

  • Market Overview
  • Over The Counter
  • Solution-Based

Global Pain Management Market Size by End-User & CAGR (2024-2031)

  • Market Overview
  • Emergency Clinics and Facilities
  • Drug Organizations
  • Clinical Gadget Organizations
  • Examination
  • Educational Establishments

Global Pain Management Market Size & CAGR (2024-2031)

  • North America (Types, Indication, Mode of Purchase, End-User)
    • USA
    • Canada
  • Europe (Types, Indication, Mode of Purchase, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Types, Indication, Mode of Purchase, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Types, Indication, Mode of Purchase, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Types, Indication, Mode of Purchase, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Teva Pharmaceutical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mallinckrodt Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endo International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Depomed
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genentech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tonix Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuSpera Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oculis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspen Laser
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hyperice
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orofacial Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pain Care Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!